OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting
November 12, 2024 08:00 ET
|
ORGANOX LIMITED; eGenesis, Inc.
OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting
OrganOx metra® System Approved for Liver Transplantation in Canada
October 02, 2024 08:15 ET
|
ORGANOX LIMITED
OrganOx metra® System Approved for Liver Transplantation in Canada
Appointment of Stephen M. Deitsch as new Chief Financial Officer
April 04, 2024 11:43 ET
|
ORGANOX LIMITED
OrganOx Appoints Stephen M. Deitsch, an experienced medtech finance leader with proven track record with IPOs, as new Chief Financial Officer.
OrganOx Raises £25 Million in Growth Round Led by Lauxera Capital Partners
July 17, 2023 02:05 ET
|
ORGANOX LIMITED
OXFORD, United Kingdom, July 17, 2023 (GLOBE NEWSWIRE) -- OrganOx Ltd (“OrganOx” or the “Company”), a world-leading medical technology company committed to making every donated organ count with...